Based on this, we believe that it is significant to routinely evaluate Tspan8 immunohistochemical staining in patients with ICC after surgery, which can provide strong support for reducing postoperative recurrence rate and mortality rate of patients. This evidence concerns the gene TSPAN8 and intrahepatic cholangiocarcinoma.